Canadian Cannabis Sales Hit C$471M in March, Up 7.4% Monthly
Statistics Canada data shows strong growth despite fewer selling days in February
Canadian cannabis retailers pulled in C$471.4 million in March, a 7.4% jump from February's revised figure of C$439.1 million, according to new data from Statistics Canada.
But the headline number tells only part of the story. When adjusted for the number of days in each month, March sales actually declined 4% on a per-day basis—a quirk driven largely by February's shorter calendar. The monthly revision also knocked C$1.4 million off February's originally reported total of C$440.5 million.
The figures underscore the Canadian market's continued maturation four years after legalization, with sales patterns now stable enough that day-count adjustments matter for accurate comparisons. March's absolute growth reflects consistent consumer demand even as the per-day metric suggests the market is finding its equilibrium.
Market Context
Canada's legal cannabis market has been wrestling with oversupply and price compression for the past year, forcing producers to rationalize operations and retailers to compete aggressively on price. The March sales data arrives as several major licensed producers prepare quarterly earnings reports that are expected to show continued margin pressure.
The C$471 million monthly figure translates to roughly C$5.7 billion in annualized sales—a substantial market, but one that's grown more slowly than many analysts predicted in 2018. Provincial differences remain stark, with Ontario and Quebec driving the bulk of sales while Alberta and British Columbia show different consumption patterns per capita.
Statistics Canada's retail data doesn't break out online versus brick-and-mortar sales, though provincial regulators have noted that physical stores continue to dominate in most markets. Ontario alone now has more than 1,500 licensed retail locations, up from just 24 at the start of 2020.
What the Numbers Mean
The per-day adjustment matters more than it might seem. February had 28 days while March had 31—a roughly 11% difference in selling days. That March's unadjusted sales grew only 7.4% suggests daily transaction volumes actually softened slightly, possibly reflecting post-holiday spending patterns or seasonal shifts in consumer behavior.
Industry observers will be watching April's numbers closely to see whether the per-day trend continues or whether March represented a temporary dip. Spring and summer typically see stronger sales in the Canadian market, driven by outdoor consumption and tourism in some provinces.
The revised February figure also signals that Statistics Canada is refining its methodology as more data comes in—a normal practice for preliminary estimates, but one that means month-to-month comparisons require careful attention to which numbers are final versus subject to revision.
Looking Ahead
Canada's cannabis market faces several headwinds in 2024, including potential federal tax adjustments and ongoing competition from the illicit market. Health Canada estimates that illegal sales still account for roughly 20-25% of total consumption, though that figure has declined from nearly 50% in the first year of legalization.
The next major data point will be Statistics Canada's first-quarter GDP figures, which should provide broader context on how cannabis retail fits into overall consumer spending patterns. With inflation moderating but economic uncertainty persisting, discretionary spending categories like cannabis could see volatility in the months ahead.
For now, the March numbers suggest steady demand—neither booming growth nor collapse, but the kind of predictable sales pattern that mature markets eventually achieve.
This article is based on original reporting by www.newcannabisventures.com.
Original Source
This article is based on reporting from New Cannabis Ventures.
Read the original articleOriginal title: "Canadian Cannabis Sales Marched Higher in March"
Related Topics
Related Stories
BusinessFederal Rescheduling Could Free $3B+ Locked in Cannabis Tax Penalties
DEA rescheduling would end IRS 280E tax penalties that forced cannabis companies into 70%+ effective tax rates, potentially unlocking $3B+ in sector-wide profits that were artificially suppressed for years.
FundCanna Lands $60M Credit Facility for Cannabis Business Loans
Cannabis lender FundCanna secured a $60 million credit line from an institutional investor managing $40 billion in assets, bringing its total capital to $75 million as cannabis operators continue facing limited banking access.
LegislationVirginia Gov. Vetoes Cannabis Sales Bill, Citing 'Rushed' Concerns
Virginia's governor vetoed a cannabis retail bill citing concerns about moving too fast, despite evidence that delayed launches—not quick ones—create market problems. The decision blocks $50 million in economic activity.
More from Alex Morgan
View all articles
Cannabis Emerges as Economic Lifeline in Collapsed States
Delaware Legislature Debates Dueling Hemp THC Regulation Bills
Minnesota Suspends Testing Lab License Amid Compliance Failures

